Gelonghui, April 24 | Hisense Pharmaceutical (001367.SZ) released its report for the first quarter of 2024, with operating income of 116 million yuan, up 8.27% year on year; net profit attributable to shareholders of listed companies was 33.3848 million yuan, up 33.55% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 32.641 million yuan, up 30.49% year on year; basic earnings per share were 0.49 yuan.
海森药业(001367.SZ)：一季度净利润3338.48万元 同比增长33.55%
Hisense Pharmaceutical (001367.SZ): Net profit of 33.3848 million yuan in the first quarter increased 33.55% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.